PubMed:10328107 / 136-320
Annnotations
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S2 | 0-184 | Sentence | denotes | BACKGROUND: Arsenic trioxide (As2O3) can induce clinical remission in patients with acute promyelocytic leukemia via induction of differentiation and programmed cell death (apoptosis). |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C4 | 12-36 | NP | denotes | Arsenic trioxide (As2O3) |
| C5 | 130-145 | NP | denotes | differentiation |
| C6 | 150-183 | NP | denotes | programmed cell death (apoptosis) |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T4 | 12-28 | other_organic_compound | denotes | Arsenic trioxide |
| T5 | 30-35 | other_organic_compound | denotes | As2O3 |
| T6 | 70-78 | multi_cell | denotes | patients |
| T7 | 84-112 | other_name | denotes | acute promyelocytic leukemia |
| T8 | 150-171 | other_name | denotes | programmed cell death |
| T9 | 173-182 | other_name | denotes | apoptosis |
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T2 | 104-112 | HP_0001909 | denotes | leukemia |
| T1 | 84-112 | HP_0004836 | denotes | acute promyelocytic leukemia |